Minimal residual disease negativity by next‐generation flow in non‐CR myeloma patients

Next‐generation flow (NGF) has detected minimal residual disease (MRD) in numerous myeloma patients who achieve a complete response (CR). However, when MRD is not detected via NGF in non‐CR patients, its clinical meaning is uncertain. Here, we investigated the correlation between MRD findings on NGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung‐Min, Yang, Naery Euphrasia, Jeong, Dajeong, Yun, Jiwon, Ryu, Sohee, Yoon, Sung‐Soo, Ahn, Yong‐Oon, Lee, Dong Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175670/
https://www.ncbi.nlm.nih.gov/pubmed/35844993
http://dx.doi.org/10.1002/jha2.103

Ejemplares similares

Ejemplares similares